首页> 外文期刊>Brazilian Journal of Medical and Biological Research >Long-term efficacy of endovascular vs open surgical repair for complicated type-B aortic dissection: a single-center retrospective study and meta-analysis
【24h】

Long-term efficacy of endovascular vs open surgical repair for complicated type-B aortic dissection: a single-center retrospective study and meta-analysis

机译:腔内与开放手术修复对复杂B型主动脉夹层的远期疗效:单中心回顾性研究和荟萃分析

获取原文
获取外文期刊封面目录资料

摘要

This study aimed to evaluate the long-term survival and risk factors of traditional open surgical repair (OSR) vs thoracic endovascular aneurysm repair (TEVAR) for complicated type-B aortic dissection (TBAD). A total of 118 inpatients (45 OSR vs 73 TEVAR) with TBAD were enrolled from January 2004 to January 2015. Kaplan-Meier curves and Cox proportional hazards analysis were performed to identify the long-term survival rate and independent predictors of survival, respectively. Meta-analysis was used to further explore the long-term efficacy of OSR and TEVAR in the eight included studies using Review Manager 5.2 software. An overall 10-year survival rate of 41.9% was found, and it was similar in the two groups (56.7% OSR vs 26.1% TEVAR; log-rank P=0.953). The risk factors of long-term survival were refractory hypertension (OR=11.1; 95%CI=1.428-86.372; P = 0.021] and preoperative aortic diameter >55 mm (OR=4.5; 95%CI=1.842-11.346; P = 0.001). Long-term survival rate did not differ significantly between OSR and TEVAR (hazard ratio=0.87; 95%CI=0.52-1.47; P = 0.61). Compared with OSR, TEVAR did not show long-term advantages for patients with TBAD. Refractory hypertension and total aortic diameter >55 mm can be used to predict the long-term survival of TBAD in the Chinese Han population.
机译:这项研究旨在评估复杂的B型主动脉夹层(TBAD)的传统开放手术修复(OSR)与胸腔内血管瘤修复(TEVAR)的长期生存和危险因素。从2004年1月至2015年1月,共入组TBAD住院患者118例(45 OSR对比73 TEVAR)。进行了Kaplan-Meier曲线和Cox比例风险分析,分别确定了长期生存率和独立的生存预测因子。使用Review Manager 5.2软件通过荟萃分析进一步探讨了OSR和TEVAR在包括在内的八项研究中的长期疗效。发现总体10年生存率为41.9%,两组相似(OSR为56.7%,TEVAR为26.1%;对数秩P = 0.953)。长期生存的危险因素是难治性高血压(OR = 11.1; 95%CI = 1.428-86.372; P = 0.021]和术前主动脉直径> 55 mm(OR = 4.5; 95%CI = 1.842-11.346; P = 0.001)。OSR和TEVAR的长期生存率无显着差异(危险比= 0.87; 95%CI = 0.52-1.47; P = 0.61)。与OSR相比,TEVAR对患有OSR的患者没有长期优势TBAD:难治性高血压和主动脉总直径> 55 mm可用于预测TBAD在中国汉族人群中的长期存活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号